Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics

Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana). GelSana will use the Fund’s investment to accelerate their research efforts, prepare for FDA regulatory submission, and build a pipeline of sustained release products.

In addition to being a portfolio company of the Fund, GelSana is also a client company of Innosphere’s accelerator program for technology and science-based startups, as the company joined one of Innosphere’s cohorts in the fall of 2020. GelSana received a first investment from Innosphere Ventures Fund back in 2020 to accelerate their product development plan.

Find out more in the Innosphere Ventures press release.

Categories: Ecosystem News